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A study of the association of plasma irisin levels and coronary artery
diseases
Guangqi Chen, Tao Li, Xiaopeng Xu, Wenhui Peng
Department of Cardiology, Shanghai Tenth People’s Hospital, Tongji
University of Medicine, Shanghai, China
OBJECTIVES Irisin is a newly discovered myokine, which is
involved in energy metabolism and associated with ‘browning’ of
the white adipose tissue, obesity, diabetes mellitus and metabolic
syndrome. It’s still uncertain that whether plasma irisin level is
associated with coronary artery diseases(CAD). The purpose of this
study is to explore the relationship between circulating irisin levels
and CAD.
METHODS A total of 209 patients complained with ‘chest discomfort’
undergone coronary angiography were enrolled in this study. They
were divided into non-CAD(n¼74) and CAD (n¼135) groups. The CAD
group was further divided into three groups: SAP (n¼52), UAP (n¼30),
AMI (n¼53). The levels of plasma irisin, clinical parameters, lipid
proﬁle and C reactive protein (CRP) were measured. and echocardi-
ography was performed on enrolled subjects.
RESULTS The levels of plasma irisin were signiﬁcantly higher in the
CAD group (124.1058.56 ng/ml) than those in the non-CAD group
(95.6659.8 ng/ml), p¼0.001. And positively associated with aortic
root diameter (0.181, p¼0.046), left ventricular posterior wall thick-
ness(0.191, p¼0.035), interventricular septum thickness (0.207,
p¼0.022), and multiple linear regression reveal that irisin concentra-
tion is associated with blood uric acid (r¼0.397, p¼0.003), serum
creatinine (r¼-2.239, p¼0.03) independently. The levels of plasma
irisin were signiﬁcantly lower in the SAP group than UAP group
(103.4861.50 ng/mL VS 133.6758.24 ng/mL, P¼0.021) and AMI
group (103.4861.50 ng/mL VS 139.2050.12 ng/mL, P¼0.002). But it
is not signiﬁcantly difference between UAP and AMI group
(133.6758.24 ng/mL VS 139.2050.12 ng/mL, P¼0.671). The plasma
irisin concentration of CAD patients with normal renal function or
abnormal renal function were 125.6959.66 ng/mL, 110.7851.09 ng/
mL (P¼0.33), respectively. After one year of follow up of AMI group
subjects, the data show that the incidence of MACEs is lower in
irisin > median group (32.14%) than irisin < median group(50%).
CONCLUSIONS The plasma irisin concentration is higher in CAD pa-
tients than non CAD subjects, and correlated with aortic root diam-
eter, left ventricular posterior wall thickness, interventricular septum
thickness, blood uric acid, serum creatinine in the CAD patients. And
gradually increasing in the subgroups of CAD(SAP, UAP, AMI). And
lower in patients of CAD with normal renal function than abnormal
renal function. The incidence of MACEs is lower in AMI subjects with
higher irisin levels undergone percutaneous coronary intervention
treatment.GW26-e0387
Thromboelastograph in the clinical application of acute coronary
syndrome
Zhiliang Chen, Lei Wang
Beijing Friendship Hospital
OBJECTIVES The purpose of this study is to clear the relationship
platelet reactivity to adenosine diphosphate by Thromboelastograph
with ischemic events after PCI.
METHODS We measured platelet reactivity to adenosine diphosphate
(ADP) by Thromboelastograph in acute coronary syndrome undergo-
ing PCI (n¼89). All patients take orally clopidogrel with loading dose
of 300 mg, or maintenance dose of 75 mg at least 3 days. According to
the result of Thromboelastograph, We divide the ADP inhibition rate
into the two groups (A group ADP inhibition rate more than 50% and B
group ADP inhibition rate less than 50%), and observe six to nine
months events of the two groups. End point events were deﬁned as
new cardiovascular events (death、myocardial infarction, myocardial
ischemia, peripheral vascular disease) and new cerebrovascular
events (cerebral infarct and hemorrhage).
RESULTS Within six to nine months after discharge, 11 of 22patients
in A group occurred events, including TIA (n¼1), unstable angina
(n¼5), variant angina pectoris (n¼1), NSTEMI(n¼1), STEMI(n¼1), car-
diac insufﬁciency(n¼1). However in B group, there were 19 events that
occurred in 67patients within six to nine months after discharge,
including death(n¼1), cerebral infarction(n¼1), NSTEMI(n¼1), unsta-
ble angina(n¼16). There was signiﬁcant statistical difference between
the two groups on gender, history of high blood pressure, ureanitrogen, platelet inhibition mediated by ADP, AA (arachidonic acid)
of platelet inhibition mediated by AA (arachidonic acid), ADP medi-
ated MA(P¼0.004,P¼0.022,P¼0.029,P¼0,P¼0,P¼0). Logistic regres-
sion analyses revealed that ADP mediated MA is the independent
predict factors of the occurrence of major cardiovascular and cere-
brovascular events (P¼0.029 ).
CONCLUSIONS All data shows that ADP mediated platelet MA value
can guidance antiplatelet therapy in patients at risk of acute coronary
syndrome, so as to reduce the incidence of end point events.
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Impact of rhBNP on reperfusion injury in the patients with acute
myocardial infarction undergoing emergency percutaneous coronary
intervention
Lijun Wang
Department of Cardiology, Afﬁliated Zhongshan hospital of Dalian
University
OBJECTIVES To investigate the effect of Lyophiluzed Recombinant
Human Brain Natriuretic Peptide (rhBNP) on myocardiac reperfusion
injury in the patients with ST-segment elevation myocardial infarc-
tion (STEMI) of anterior wall undergoing emergency percutaneous
coronary intervention (PCI).
METHODS This prospective study included patients with acute STEMI
of anterior wall undergoing emergency PCI hospitalized at Afﬁliated
Zhongshan hospital of Dalian University from January 2013 to October
2014. Patientswith SBP< 100mmHg, culprit vessel blood ﬂowof TIMI 2-
3 before PCI, and renal insufﬁciency were excluded. 60 patients were
randomly divided into rhBNP group (n ¼ 29) and control group (n ¼ 31).
In the rhBNP group, rhBNP was injected by intravenous with 1.5 ug/kg
between 3minutes and 5minutes followed with continuous infusion of
0.01ug-1.min-1, and the totle dose of rhBNP was 0.5g in each patient.
Other procedures of rhBNP group were similar with those of control
group. Patients’ demographic, clinical and angiographic characteristics
were obtained. The supemxide dismutase (SOD), malonaldehyde
(MDA) were measured. The parameters presentingmyocardial infusion
including corrected TIMI framecount (CTFC) and myocardial blush
grade (MBG) were calculated. The reperfusion arrhythmias was recor-
ded. Left ventricular ejection fraction (LVEF) of the recruited patients
was assessed at 3-5 days and 6 weeks after emergency PCI.
RESULTS The serum level of MDA signiﬁcantly lower(5.521.21
vs.6.721.22, p<0.05), and serum SOD level was signiﬁcantly higher in
rhBNP group than those in control group (84.93.5214.28
vs.73.9213.71, p<0.05). Compared with control group, CTFC was
signiﬁcantly lower in rhBNP group (24.233.65 vs. 26.973.28,
p<0.05). The MBG  grade 2 was more common(86.21% vs. 61.29%,
p <0.05), and incidence of reperfusion arrhythmias was less common
in rhBNP group than those in control (all p<0.05). RhBNP group pa-
tients’ LVEF was higher than that in control group at both 3 days and 6
weeks after emergency PCI (53.829.26 vs. 51.4510.12 and
55.1211.54 vs. 52.1713.03 respectively, all p<0.05). No signiﬁcant
differences including age, gender, hypertension, diabetes, hyperlip-
idemia, history of previous myocardial infaction, blood pressure and
heart rate before PCI, time from onset to balloon, diseased vessel
number and culprit lesion site were observed between the two groups.
CONCLUSIONS RhBNP can effectively reduce myocardial ischemia-
reperfusion injury in patients with STEMI of anterior wall after
emergency PCI.
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Characteristics of coagulation-anticoagulation-ﬁbrinolytic system related
gene mRNA expression in patients with acute myocardial infarction and
stable angina pectoris
Chuanrong Li, Lemin Wang
Department of Cardiology, Tongji Hospital, Tongji University School of
Medicine, Shanghai, China
OBJECTIVES The objective of this study was to investigate expres-
sion differences of coagulation -anticoagulation - ﬁbrinolytic system
related genes mRNA among acute myocardial infarction (AMI), stable
angina pectoris (SAP) and control groups, and then analyze system-
atically their dynamic trends in myocardial ischemia as well as arterial
thrombosis.
METHODS WholeHumanGenomeOligoMicroarrayswereappliedtoassess
the differential expression characteristics of coagulation -anticoagulation -
ﬁbrinolytic system relatedmRNAs in patients with AMI (n¼20), SAP (n¼20)
and controls (n¼20).
